These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 3572754)
1. Determination of binding parameters of macrolides, lincosamides, and streptogramins to Legionella pneumophila. Fournet MP; Zini R; Deforges L; Duval J; Tillement JP J Pharm Sci; 1987 Feb; 76(2):153-6. PubMed ID: 3572754 [TBL] [Abstract][Full Text] [Related]
2. Binding studies of macrolides, lincosamides and streptogramins to Streptococcus G group using [3H]-erythromycin. Fournet MP; Deforges L; Zini R; Barre J; Tillement JP Biochem Pharmacol; 1987 Oct; 36(20):3495-500. PubMed ID: 3118878 [TBL] [Abstract][Full Text] [Related]
3. Binding parameters and microbiological activity of macrolides, lincosamides and streptogramins against Staphylococcus aureus. Fournet MP; Barre J; Zini R; Deforges L; Duval J; Tillement JP J Pharm Pharmacol; 1987 Apr; 39(4):319-22. PubMed ID: 2884302 [TBL] [Abstract][Full Text] [Related]
4. [Activity of macrolides and fluoroquinolones against intracellular Legionella pneumophila]. Yu LL; Hu BJ; Huang SL; Zhou ZY; Tao LL Zhonghua Jie He He Hu Xi Za Zhi; 2011 Jun; 34(6):409-12. PubMed ID: 21781510 [TBL] [Abstract][Full Text] [Related]
5. Susceptibility of Legionella spp. to mycinamicin I and II and other macrolide antibiotics: effects of media composition and origin of organisms. Edelstein PH; Pasiecznik KA; Yasui VK; Meyer RD Antimicrob Agents Chemother; 1982 Jul; 22(1):90-3. PubMed ID: 7125633 [TBL] [Abstract][Full Text] [Related]
6. Effect of levofloxacin, erythromycin or rifampicin pretreatment on growth of Legionella pneumophila in human monocytes. Smith RP; Baltch AL; Franke M; Hioe W; Ritz W; Michelsen P J Antimicrob Chemother; 1997 Nov; 40(5):673-8. PubMed ID: 9421315 [TBL] [Abstract][Full Text] [Related]
8. Minimum inhibitory concentration (MIC) distribution among wild-type strains of Legionella pneumophila identifies a subpopulation with reduced susceptibility to macrolides owing to efflux pump genes. Vandewalle-Capo M; Massip C; Descours G; Charavit J; Chastang J; Billy PA; Boisset S; Lina G; Gilbert C; Maurin M; Jarraud S; Ginevra C Int J Antimicrob Agents; 2017 Nov; 50(5):684-689. PubMed ID: 28782709 [TBL] [Abstract][Full Text] [Related]
9. Comparison of charcoal- and starch-based media for testing susceptibilities of Legionella species to macrolides, azalides, and fluoroquinolones. Pendland SL; Martin SJ; Chen C; Schreckenberger PC; Danziger LH J Clin Microbiol; 1997 Nov; 35(11):3004-6. PubMed ID: 9350781 [TBL] [Abstract][Full Text] [Related]
10. Application of the Etest to antimicrobial susceptibility testing of Legionella spp. Rhomberg PR; Bale MJ; Jones RN Diagn Microbiol Infect Dis; 1994 Jul; 19(3):175-8. PubMed ID: 7820999 [TBL] [Abstract][Full Text] [Related]
11. Antibacterial activities of gemifloxacin, levofloxacin, gatifloxacin, moxifloxacin and erythromycin against intracellular Legionella pneumophila and Legionella micdadei in human monocytes. Baltch AL; Bopp LH; Smith RP; Michelsen PB; Ritz WJ J Antimicrob Chemother; 2005 Jul; 56(1):104-9. PubMed ID: 15941776 [TBL] [Abstract][Full Text] [Related]
12. Susceptibility of Legionella pneumophila to eight antimicrobial agents including four macrolides under different assay conditions. Liebers DM; Baltch AL; Smith RP; Hammer MC; Conroy JV J Antimicrob Chemother; 1989 Jan; 23(1):37-41. PubMed ID: 2526110 [TBL] [Abstract][Full Text] [Related]
13. Determination of the activity on Legionella of eight macrolides and related agents by comparative testing on three media. Bornstein N; Roudier C; Fleurette J J Antimicrob Chemother; 1985 Jan; 15(1):17-22. PubMed ID: 3972756 [TBL] [Abstract][Full Text] [Related]
14. Susceptibility of Legionella species to antimicrobial agents. Chen SC; Paul ML; Gilbert GL Pathology; 1993 Apr; 25(2):180-3. PubMed ID: 8367199 [TBL] [Abstract][Full Text] [Related]
15. Comparative in vitro activity and post-antibiotic effect of gemifloxacin against Legionella spp. Dubois J; St-Pierre C J Antimicrob Chemother; 2000 Apr; 45 Suppl 1():41-6. PubMed ID: 10824031 [TBL] [Abstract][Full Text] [Related]
16. Activities of tigecycline and comparators against Legionella pneumophila and Legionella micdadei extracellularly and in human monocyte-derived macrophages. Bopp LH; Baltch AL; Ritz WJ; Michelsen PB; Smith RP Diagn Microbiol Infect Dis; 2011 Jan; 69(1):86-93. PubMed ID: 21146719 [TBL] [Abstract][Full Text] [Related]
17. In vitro activity of various antibiotics against clinical strains of Legionella species isolated in Japan. Miyashita N; Kobayashi I; Higa F; Aoki Y; Kikuchi T; Seki M; Tateda K; Maki N; Uchino K; Ogasawara K; Kurachi S; Ishikawa T; Ishimura Y; Kanesaka I; Kiyota H; Watanabe A J Infect Chemother; 2018 May; 24(5):325-329. PubMed ID: 29459000 [TBL] [Abstract][Full Text] [Related]
18. Sensitivity and resistance of Legionella pneumophila to some antibiotics and combinations of antibiotics. Moffie BG; Mouton RP J Antimicrob Chemother; 1988 Oct; 22(4):457-62. PubMed ID: 3204075 [TBL] [Abstract][Full Text] [Related]
19. Activity of azithromycin, clarithromycin, roxithromycin, dirithromycin, quinupristin/dalfopristin and erythromycin against Legionella species by intracellular susceptibility testing in HL-60 cells. Stout JE; Arnold B; Yu VL J Antimicrob Chemother; 1998 Feb; 41(2):289-91. PubMed ID: 9533475 [TBL] [Abstract][Full Text] [Related]
20. Susceptibility of Legionella pneumophila to antimicrobial agents and the presence of the efflux pump LpeAB. Natås OB; Brekken AL; Bernhoff E; Hetland MAK; Löhr IH; Lindemann PC J Antimicrob Chemother; 2019 Jun; 74(6):1545-1550. PubMed ID: 30815687 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]